Literature DB >> 9588955

Xylosylation of alternatively spliced isoforms of Alzheimer APP by xylosyltransferase.

C Götting1, J Kuhn, T Brinkmann, K Kleesiek.   

Abstract

Acceptor affinities of UDP-D-xylose:proteoglycan core protein beta-D-xylosyltransferase (XT) recognition signals in synthetic L-APP and L-APLP2 homologous peptides were determined. The Michaelis-Menten constants (KM) of the L-APP peptide TENEGSGLTNIK and the L-APLP2 peptide SENEGSGMAEQK were 20.1 and 18.9 microM, respectively. Therefore, the peptides proved to be as good acceptors for XT as the bikunin aminoterminus homologous peptide (KM = 22 microM). Due to the occurrence of L-APP and L-APLP2 transcripts in human brain tissue, XT activity was measured in human liquor cerebrospinalis. Mean values were calculated as 0.22 mU/L in males and 0.47 mU/L in females without disturbance of blood brain barrier. In addition, in homogenized rat brain tissue a mean XT activity of 0.75 mU/L was determined. Furthermore, XT activity was investigated in 21 different human cell lines. In 7 cell lines an enzyme activity was not detected in either extracellular space or cytoplasma. Our findings indicate that XT is not ubiquitously expressed in human cell types.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588955     DOI: 10.1023/a:1022549121672

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  8 in total

1.  Elevated xylosyltransferase I activities in pseudoxanthoma elasticum (PXE) patients as a marker of stimulated proteoglycan biosynthesis.

Authors:  Christian Götting; Doris Hendig; Alexandra Adam; Sylvia Schön; Veronika Schulz; Christiane Szliska; Joachim Kuhn; Knut Kleesiek
Journal:  J Mol Med (Berl)       Date:  2005-08-24       Impact factor: 4.599

2.  Polymorphisms in the xylosyltransferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course.

Authors:  S Schön; V Schulz; C Prante; D Hendig; C Szliska; J Kuhn; K Kleesiek; C Götting
Journal:  J Med Genet       Date:  2006-03-29       Impact factor: 6.318

3.  Involvement of a cysteine protease in the secretion process of human xylosyltransferase I.

Authors:  Claudia Pönighaus; Joachim Kuhn; Knut Kleesiek; Christian Götting
Journal:  Glycoconj J       Date:  2010-03-03       Impact factor: 2.916

4.  Human xylosyltransferase I and N-terminal truncated forms: functional characterization of the core enzyme.

Authors:  Sandra Müller; Jennifer Disse; Manuela Schöttler; Sylvia Schön; Christian Prante; Thomas Brinkmann; Joachim Kuhn; Knut Kleesiek; Christian Götting
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

5.  Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum.

Authors:  Eduard Condac; George L Dale; Diane Bender-Neal; Beatrix Ferencz; Rheal Towner; Myron E Hinsdale
Journal:  Glycobiology       Date:  2009-04-23       Impact factor: 4.313

6.  Human xylosyltransferase I: functional and biochemical characterization of cysteine residues required for enzymic activity.

Authors:  Sandra Müller; Manuela Schöttler; Sylvia Schön; Christian Prante; Thomas Brinkmann; Joachim Kuhn; Christian Götting; Knut Kleesiek
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

7.  The missing "link": an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutation.

Authors:  Julia Schreml; Burak Durmaz; Ozgur Cogulu; Katharina Keupp; Filippo Beleggia; Esther Pohl; Esther Milz; Mahmut Coker; Sema Kalkan Ucar; Gudrun Nürnberg; Peter Nürnberg; Joachim Kuhn; Ferda Ozkinay
Journal:  Hum Genet       Date:  2013-08-27       Impact factor: 4.132

Review 8.  Recent advances on glycosyltransferases involved in the biosynthesis of the proteoglycan linkage region.

Authors:  Jia Gao; Xuefei Huang
Journal:  Adv Carbohydr Chem Biochem       Date:  2021-11-24       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.